vs
CHICAGO RIVET & MACHINE CO(CVR)与Protalix BioTherapeutics, Inc.(PLX)财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是CHICAGO RIVET & MACHINE CO的1.5倍($9.1M vs $6.0M),CHICAGO RIVET & MACHINE CO净利率更高(-19.3% vs -60.3%,领先41.0%),CHICAGO RIVET & MACHINE CO同比增速更快(45.9% vs -49.9%),Protalix BioTherapeutics, Inc.自由现金流更多($1.6M vs $24.3K),过去两年Protalix BioTherapeutics, Inc.的营收复合增速更高(-6.7% vs -12.7%)
芝加哥气动(简称CP)是一家工业制造企业,主营动力工具、空气压缩机、发电机、照明灯塔及液压设备,产品通过全球分销网络销往150多个国家,业务覆盖工业生产工具、汽车维修、采矿维保检修、工程建设、基础设施设备等多个领域。
Protalix BioTherapeutics是一家以色列制药企业,核心产品为植物源酶制剂他利苷酶阿尔法,该产品已获美国食品药品监督管理局批准,用于治疗戈谢病,专注于开发创新生物技术药物服务患者需求。
CVR vs PLX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $6.0M | $9.1M |
| 净利润 | $-1.2M | $-5.5M |
| 毛利率 | 2.7% | 49.4% |
| 营业利润率 | -15.3% | -51.1% |
| 净利率 | -19.3% | -60.3% |
| 营收同比 | 45.9% | -49.9% |
| 净利润同比 | 68.0% | -184.8% |
| 每股收益(稀释后) | — | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $6.0M | $9.1M | ||
| Q3 25 | $7.4M | $17.9M | ||
| Q2 25 | $7.3M | $15.7M | ||
| Q1 25 | $7.2M | $10.1M | ||
| Q4 24 | $4.1M | $18.2M | ||
| Q3 24 | $7.0M | $18.0M | ||
| Q2 24 | $8.1M | $13.5M | ||
| Q1 24 | $7.9M | — |
| Q4 25 | $-1.2M | $-5.5M | ||
| Q3 25 | $67.6K | $2.4M | ||
| Q2 25 | $-395.0K | $164.0K | ||
| Q1 25 | $401.0K | $-3.6M | ||
| Q4 24 | $-3.6M | $6.5M | ||
| Q3 24 | $-1.4M | $3.2M | ||
| Q2 24 | $142.1K | $-2.2M | ||
| Q1 24 | $-698.0K | — |
| Q4 25 | 2.7% | 49.4% | ||
| Q3 25 | 18.1% | 53.4% | ||
| Q2 25 | 13.4% | 62.5% | ||
| Q1 25 | 22.9% | 19.1% | ||
| Q4 24 | -43.7% | 78.7% | ||
| Q3 24 | 10.0% | 53.4% | ||
| Q2 24 | 17.6% | 29.8% | ||
| Q1 24 | 9.5% | — |
| Q4 25 | -15.3% | -51.1% | ||
| Q3 25 | 0.9% | 11.9% | ||
| Q2 25 | -5.7% | 7.5% | ||
| Q1 25 | 1.0% | -41.0% | ||
| Q4 24 | -86.4% | 39.6% | ||
| Q3 24 | -11.8% | 22.2% | ||
| Q2 24 | 1.3% | -18.0% | ||
| Q1 24 | -11.5% | — |
| Q4 25 | -19.3% | -60.3% | ||
| Q3 25 | 0.9% | 13.2% | ||
| Q2 25 | -5.4% | 1.0% | ||
| Q1 25 | 5.5% | -35.8% | ||
| Q4 24 | -88.0% | 35.6% | ||
| Q3 24 | -20.8% | 18.0% | ||
| Q2 24 | 1.8% | -16.4% | ||
| Q1 24 | -8.9% | — |
| Q4 25 | — | $-0.06 | ||
| Q3 25 | — | $0.03 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.7M | $14.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $18.8M | $48.2M |
| 总资产 | $23.3M | $82.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
| Q4 25 | $1.7M | $14.7M | ||
| Q3 25 | $1.7M | $13.6M | ||
| Q2 25 | $1.2M | $17.9M | ||
| Q1 25 | $765.6K | $19.5M | ||
| Q4 24 | $2.2M | $19.8M | ||
| Q3 24 | $2.2M | $27.4M | ||
| Q2 24 | $2.6M | $23.4M | ||
| Q1 24 | $2.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $0 | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $18.8M | $48.2M | ||
| Q3 25 | $20.0M | $52.9M | ||
| Q2 25 | $20.0M | $49.9M | ||
| Q1 25 | $20.4M | $45.2M | ||
| Q4 24 | $20.0M | $43.2M | ||
| Q3 24 | $23.7M | $32.4M | ||
| Q2 24 | $25.2M | $28.6M | ||
| Q1 24 | $25.2M | — |
| Q4 25 | $23.3M | $82.3M | ||
| Q3 25 | $24.0M | $82.3M | ||
| Q2 25 | $23.6M | $78.5M | ||
| Q1 25 | $24.1M | $73.9M | ||
| Q4 24 | $23.4M | $73.4M | ||
| Q3 24 | $26.4M | $61.6M | ||
| Q2 24 | $27.3M | $91.5M | ||
| Q1 24 | $27.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $116.4K | $2.0M |
| 自由现金流经营现金流 - 资本支出 | $24.3K | $1.6M |
| 自由现金流率自由现金流/营收 | 0.4% | 17.8% |
| 资本支出强度资本支出/营收 | 1.5% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.6M | $-13.6M |
8季度趋势,按日历期对齐
| Q4 25 | $116.4K | $2.0M | ||
| Q3 25 | $638.0K | $-3.7M | ||
| Q2 25 | $28.2K | $-5.2M | ||
| Q1 25 | $-2.0M | $-5.1M | ||
| Q4 24 | $-60.1K | $4.0M | ||
| Q3 24 | $-58.2K | $4.1M | ||
| Q2 24 | $363.5K | $-3.6M | ||
| Q1 24 | $-398.8K | — |
| Q4 25 | $24.3K | $1.6M | ||
| Q3 25 | $492.1K | $-4.2M | ||
| Q2 25 | $-22.8K | $-5.7M | ||
| Q1 25 | $-2.1M | $-5.4M | ||
| Q4 24 | $-118.1K | $3.6M | ||
| Q3 24 | $-368.9K | $4.0M | ||
| Q2 24 | $58.0K | $-3.8M | ||
| Q1 24 | $-491.8K | — |
| Q4 25 | 0.4% | 17.8% | ||
| Q3 25 | 6.7% | -23.7% | ||
| Q2 25 | -0.3% | -36.2% | ||
| Q1 25 | -28.3% | -53.0% | ||
| Q4 24 | -2.9% | 19.6% | ||
| Q3 24 | -5.3% | 22.4% | ||
| Q2 24 | 0.7% | -28.1% | ||
| Q1 24 | -6.3% | — |
| Q4 25 | 1.5% | 4.4% | ||
| Q3 25 | 2.0% | 2.8% | ||
| Q2 25 | 0.7% | 2.8% | ||
| Q1 25 | 0.6% | 3.0% | ||
| Q4 24 | 1.4% | 2.3% | ||
| Q3 24 | 4.5% | 0.5% | ||
| Q2 24 | 3.8% | 1.3% | ||
| Q1 24 | 1.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | 9.44× | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | -5.01× | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | 2.56× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVR
| Fastener | $5.1M | 85% |
| Other | $890.7K | 15% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |